Introduction
One approach to reducing childhood mortality in sub Saharan Africa is through home-based treatment (HBT) of malaria [1, 2] . This ensures early detection, treatment and better compliance. As attractive as this approach may seem, can it reduce mortality, especially if a drug with a treatment failure rate of 36% [3] (chloroquine) is used? This study simulated HBT using frequent home visits and free medical treatment among children <5 years old in rural Burkina Faso.
Methods
A total of 867 children were recruited from one town and three villages in the Nouna Demographic Surveillance System (DSS) [4] . Trained non-medical interviewers visited each child every week at home from 1 December 2003 to 30 November 2004. During visits, children were tested for fever and those with temperatures 37. 5 C received chloroquine according to the then national treatment guidelines (i.e. 10 mg/kg days 0 and 1, then 5 mg/kg on day 2). Blood samples were then collected by finger prick for microscopic examination for malaria parasites. Children who did not improve on treatment were referred to the next appropriate level of heath care. Indirect standardization was used to calculate the standardized mortality ratio (SMR) by dividing observed deaths (study cohort, intervention group) by expected ones (based on age-specific mortality rates for the <5 years age group from the 2003 DSS data, standard rate and control group). Based on methods by Breslow and Day (1987) [5] , 568 personyears would be required to detect an SMR of 0.56.
Results
Of 867 children, 14 were lost to follow-up because of out-migration, and 15 died. The age-specific mortality rate (mid year population ¼ 3453) in 2003 was 22.9/1000. For the cohort, the mortality rate was 21.1/1000. The difference was not statistically significant (SMR ¼ 0.92; 95% CI 0.50-1.55). At none of the four sites was SMR significantly less than 1.00 (Table 1) . Discussion There was no significant difference between mortality rates of the intervention and control groups. Of the 15 deceased children, seven were febrile prior to death, of which five had Plasmodium falciparum density ranging from 600 to 33 000 parasites/ml. All five occurred during the dry season when immunity is low and malaria incidence is lower (59.0/1000) than in the rainy season (118.7/1000). The deceased children were all <36 months old and hence, of a high-risk age, except one, who was 41 months old. Malaria was therefore a direct cause of death in our cohort and could have contributed to other deaths.
Our study raises questions as to what drug choices remain for HBT strategies. Although we did more than the standard HBT approach [1] , there was no significant impact on mortality. Using a drug with similar efficacy in the area would therefore have little impact or worse. The introduction of Artemisininbased combination therapy (ACT) in many malariaendemic countries raises new challenges for the HBT approach. These include high cost, more complicated regimen and possibly poor compliance. 
